Results 281 to 290 of about 9,613,208 (373)

Changes in serum T₃ T₄ and TSH before and after the T₃-suppression test in patients treated for Graves' disease

, 1977
Hajime TAMA, Hiroyuki Suematsu, Masahiro ESAKI, Nobuo KURAKAWA, Hiroyuki Aoki, Kanji Kuma, F Matsuzaka, Akira Miyauchi   +7 more
openalex   +2 more sources

Targeting Neutrophil/Eosinophil Extracellular Traps by Aptamer‐Functionalized Nanosheets to Overcome Recalcitrant Inflammatory Disorders

Advanced Science, EarlyView.
In this study, C‐TAH, as multifunctional nanosheets, is developed with tannic acid and histone aptamer coverage. C‐TAH displays mild cytotoxicity, robust dsDNA and NETs/EETs binding efficiency, and potent antioxidant and antibacterial ability in vitro. C‐TAH treatment ameliorates dysregulated inflammation and restores hearing function in animal models,
Yongqiang Xiao, Xinyue Wang, Ming Liu, Xiao Fu, Nanfeng Zhang, Wenqing Yang, Junyi Ge, Yangyang Li, Duan Ma, Jing Ma, Weiping Wen, Dongdong Ren, Tianyu Zhang, Zhaoxu Tu   +13 more
wiley   +1 more source

Thyroid peroxidase antibodies and their role in predicting outcomes in Graves' disease treatment. [PDF]

Front Endocrinol (Lausanne)
Gewert K, Topi G, Planck T, Calissendorff J.   +3 more
europepmc   +1 more source

Radioiodine (131I) Therapy of Graves' Disease: Use of the New High Resolutional Ultrasonic Scanner for the Determination of the Accurate Weight of the Thyroid Gland.

, 1989
Yuji Nagayama, Kiyoto Ashizawa, KEIICHI MATSUO, Shuji Inoue, SEIJIRO HARAKAWA, Hideshi Hirayu, Shunichi Yamashita, Motomori Izumi, Shigenobu Nagataki   +8 more
openalex   +2 more sources

The Immune Microenvironment: New Therapeutic Implications in Organ Fibrosis

Advanced Science, EarlyView.
This review summarizes recent advances in understanding the immune microenvironment's role in fibrosis, focusing on phenotypic/functional alterations of immune cells and their dynamic interactions with other cellular constituents within tissues. The authors further explore therapeutic opportunities and challenges in targeting immune microenvironment ...
Xiangqi Chen, Chuan Wu, Fei Tang, Jingyue Zhou, Li Mo, Yanping Li, Jinhan He   +6 more
wiley   +1 more source

Treatment of Graves' Disease: Faster Remission or Longer but Safe, That Is the Question. [PDF]

Endocrinol Metab (Seoul)
Jung CH.
europepmc   +1 more source

A case of Graves' disease with anti-triiodothyronine antibodies.

, 1985
Shigeki Sakata, Takashi Komaki, Shigenori NAKAMURA, Keita Kamikubo, Kaoru Takakuwa, Masaaki KAMETANI, Naoki Tokimitsu, Kiyoshi Miura   +7 more
openalex   +2 more sources

Thyrotropin and growth promoting immunoglobulin (TGI) of FRTL-5 cells have no growth stimulating activity on human thyroid epithelial cell cultures [PDF]

, 1987
Bay, V., Dwenger, M., Engel, U., Fenzi, G. F., Ingbar, S. H., Mansky, T., Mckenzie, J. M., Pinchera, Aldo, Scriba, Peter Christian, Wenzel, B. E.   +9 more
core  

A Wearable In‐Pad Diagnostic for the Detection of Disease Biomarkers in Menstruation Blood

Advanced Science, EarlyView.
MenstruAI integrates a paper‐based biosensor into sanitary pads to detect biomarkers in menstrual blood, enabling accessible, lab‐free diagnostics health. The platform supports early disease detection, especially in underserved communities, while challenging menstrual stigma and opening pathways for scalable, inclusive, and sustainable population ...
Lucas Dosnon, Thomas Rduch, Charlotte Meyer, Inge K. Herrmann   +3 more
wiley   +1 more source

Comparing antithyroid drugs vs. radioactive iodine in paediatric Graves' disease: literature review. [PDF]

Thyroid Res
Sinha A, Oza R, Sangha BK, Akhavan-Mofrad A, Suddhi A.   +4 more
europepmc   +1 more source